Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Grifols (OZTA) Price & Analysis

OZTA Stock Chart & Stats

€10.81€0.02(0.14%)
At close: 4:00 PM EDT
EUR 9.5EUR 10EUR 10.54 Aug19 Aug31 Aug3 Sep30 Sep14 Oct28 Oct
Day’s Range
EUR 10.77 - EUR 10.81
52-Week Range
EUR 8.42 - EUR 11.56
Previous Close
EUR 10.79
Volume
0
Average Volume (3M)
140
Market Cap
EUR 6.52B
Enterprise Value
EUR 16.54B
Total Cash (Recent Filing)
EUR 529.00M
Total Debt (Recent Filing)
EUR 8.52B
Price to Earnings (P/E)
16.4
Beta
0.62
Next Earnings
Nov 02, 2026
EPS Estimate
0.28
Next Dividend Ex-Date
N/A
Dividend Yield
0.75%

Bulls Say, Bears Say

Bulls Say

Integrated Plasma Platform

Vertical integration gives Grifols control across plasma collection, manufacturing, and distribution. This can support supply security, production coordination, and scale economies, strengthening the company’s ability to serve hospitals and healthcare providers over multiple quarters.

Profitability Recovery

The recovery in profitability indicates that operating performance has improved materially from the 2023 low point. Mid-teen operating margins provide a stronger base for reinvestment and debt service, although net earnings remain less robust than operating results.

Improved Free Cash Flow

A shift to solidly positive free cash flow shows that the business is converting operations into internally generated funding more effectively. This improves financial resilience, supports investment in plasma capacity, and can help address leverage over the next several quarters.

Bears Say

Elevated Leverage

Persistently high debt relative to equity limits financial flexibility and leaves less room for operational setbacks or large strategic investments. Leverage also increases the importance of sustained cash generation, making balance-sheet improvement a continuing business priority.

TTM Revenue Decline

The sharp TTM revenue contraction signals a meaningful slowdown after several years of annual growth. If it persists, lower scale and weaker commercial momentum could pressure utilization, margins, and the company’s ability to deleverage through operating growth.

Inconsistent Cash Conversion

Recent free cash flow is positive, but uneven operating cash conversion makes the earnings base less dependable for funding obligations. Historical swings, including negative operating cash flow, reduce confidence that cash generation will remain consistent while leverage is elevated.

Grifols News

OZTA FAQ

What was Grifols’s price range in the past 12 months?
Grifols lowest stock price was €8.42 and its highest was €11.56 in the past 12 months.
What is Grifols’s market cap?
Grifols’s market cap is €6.52B.
When is Grifols’s upcoming earnings report date?
Grifols’s upcoming earnings report date is Nov 02, 2026 which is in 1 day.
How were Grifols’s earnings last quarter?
Grifols released its earnings results on Jul 28, 2026. The company reported €0.226 earnings per share for the quarter, missing the consensus estimate of €0.228 by -€0.002.
Is Grifols overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Grifols pay dividends?
Grifols does not currently pay dividends.
What is Grifols’s EPS estimate?
Grifols’s EPS estimate is 0.28.
How many shares outstanding does Grifols have?
Grifols has 426,129,800 shares outstanding.
What happened to Grifols’s price movement after its last earnings report?
Grifols reported an EPS of €0.226 in its last earnings report, missing expectations of €0.228. Following the earnings report the stock price went up 1.976%.
Which hedge fund is a major shareholder of Grifols?
Currently, no hedge funds are holding shares in DE:OZTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology